Keyphrases
AIDS/HIV
31%
Anemia
28%
Aortic Dissection
13%
B-CLL
33%
Binet Stage
12%
Bleeding
12%
Blood Transfusion
14%
CD38
17%
Chemotherapy
17%
Chronic Lymphocytic Leukemia
100%
Clinical Response
14%
Collagen
24%
Combination Chemotherapy
22%
Endothelial Cells
12%
Epidemiology
13%
Fibronectin
21%
Fresh Frozen Plasma
22%
HHV-8
25%
High Affinity
19%
HIV Status
12%
Human Immunodeficiency Virus Infection
13%
Immune Thrombocytopenic Purpura
13%
Integrin
16%
Integrin Receptor
12%
Interleukin-11 (IL-11)
13%
Interleukin-11 Receptor
22%
Israel
50%
Israeli
18%
Kaposi Sarcoma
13%
Kaposi's Sarcoma-associated Herpesvirus
15%
Leukemia Patients
26%
Ligand Binding
19%
Metastasis
12%
Neutropenia
15%
Non-Hodgkin Lymphoma
15%
Platelets
43%
Pleural Effusion
16%
Primary Effusion Lymphoma
25%
Primary Sjgren's Syndrome
12%
Prognostic Factors
13%
Prognostic Marker
12%
Prognostic Significance
25%
Rituximab
41%
Therapeutic Potential
14%
Thrombin
22%
Thrombocytopenia
21%
Tumor Cells
21%
Tumor Necrosis Factor-α
16%
Von Willebrand Factor
14%
Working Diagnosis
15%
Medicine and Dentistry
Adenocarcinoma
11%
Anemia
37%
Antiretroviral Therapy
11%
Aortic Dissection
13%
Arterial Embolization
11%
Arterial Pathology
11%
Artery Occlusion
11%
B-Cell Chronic Lymphocytic Leukemia
100%
Biological Therapy
13%
Bleeding
12%
Blood Transfusion
18%
Cohort Effect
13%
Combination Chemotherapy
12%
Cytopenia
11%
Decitabine
11%
Diseases
53%
Endothelial Cell
11%
Fever of Unknown Origin
11%
Fresh Frozen Plasma
22%
Gray Platelet Syndrome
11%
Hepatitis B
11%
Highly Active Antiretroviral Therapy
11%
Hodgkin's Lymphoma
11%
Human Herpesvirus 8
16%
Human Immunodeficiency Virus
46%
Human Immunodeficiency Virus Infection
13%
Idiopathic Thrombocytopenic Purpura
19%
Immunoglobulin
11%
Lamivudine
11%
Membrane Antigen
13%
Multiple Myeloma
11%
Myelodysplastic Syndrome
11%
Neutropenia
12%
Non-Hodgkin Lymphoma
21%
Overall Survival
13%
Parvovirus B19
11%
Platelet
14%
Pleura Effusion
16%
Prevalence
16%
Primary Effusion Lymphoma
24%
Prognostic Factor
16%
Protein C Deficiency
11%
Receptor
17%
Retrospective Study
11%
Rituximab
44%
Splenectomy
11%
Splenomegaly
11%
Thrombin
11%
Thrombocytopenia
21%
Tumor Cell
12%
Pharmacology, Toxicology and Pharmaceutical Science
Agranulocytosis
11%
Anemia
11%
Autoimmune Hemolytic Anemia
7%
Beta 2 Microglobulin
5%
Chemotherapy
28%
Chronic Lymphatic Leukemia
88%
Cytopenia
11%
Decitabine
11%
Diseases
20%
Fibronectin
17%
Fresh Frozen Plasma
22%
Hepatitis B
11%
Herpesviridae
5%
HIV
33%
Hodgkin Disease
11%
Human Immunodeficiency Virus Infection
13%
Human Parvovirus B19
11%
Idiopathic Thrombocytopenic Purpura
8%
Immunoglobulin
11%
Integrin
14%
Interleukin 11
13%
Interleukin 11 Receptor
22%
Lamivudine
11%
Lymphadenopathy
6%
Melanoma
11%
Messenger RNA
5%
Monoclonal Antibody
5%
Multiple Myeloma
11%
Myelodysplastic Syndrome
11%
Myeloma
5%
Neoplasm
26%
Neutropenia
12%
Nonhodgkin Lymphoma
13%
Opportunistic Infection
6%
Overall Survival
8%
Paraproteinemia
6%
Prednisone
8%
Prevalence
11%
Primary Effusion Lymphoma
11%
Prolymphocytic Leukemia
11%
Receptor
7%
Remission
14%
Rituximab
44%
Syndrome
22%
Thrombin
22%
Thrombocytopenia
13%
Thrombotic Thrombocytopenic Purpura
11%
Tumor Necrosis Factor
11%
Verapamil
11%
Von Willebrand Factor
12%